Expanded Phase I Pazopanib and Everolimus in Advanced Solid Tumors and Previously Treated Advanced Urothelial Cancer
Clinical trial NCT01184326 · COMPLETED
Trial details
- NCT number
- NCT01184326
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2017-03-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.